Insider Surge: Certara Execs Buy 15,757 Shares as RSUs Vest, Signaling Confidence Amid Sharp Stock Decline
Insider buying surge at Certara Inc. shows executive confidence amid a 62% YTD decline—an insider‑led potential upside, but investors should weigh the company’s high‑risk, undervalued biotech profile before buying.
4 minutes to read

